Trial Profile

Phase 1 Clinical trial of ABS-101 for Inflammatory bowel diseases

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 04 Apr 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ABS 101 (Primary)
Indications Inflammatory bowel diseases
Focus Adverse reactions
Sponsors AbSci

Most Recent Events

04 Apr 2025 New trial record
18 Mar 2025 According to Absci media release, the company plans to initiate Phase 1 trial for ABS-101 in the first half of 2025, interim data readout expected in the second half of 2025.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com